Physiological and pathological consequences of exosomes at the blood–brain-barrier interface
Open Access
- 19 May 2023
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 21 (1) , 1-22
Abstract
Blood–brain barrier (BBB) interface with multicellular structure controls strictly the entry of varied circulating macromolecules from the blood-facing surface into the brain parenchyma. Under several pathological conditions within the central nervous system, the integrity of the BBB interface is disrupted due to the abnormal crosstalk between the cellular constituents and the recruitment of inflammatory cells. Exosomes (Exos) are nano-sized extracellular vesicles with diverse therapeutic outcomes. These particles transfer a plethora of signaling molecules with the potential to modulate target cell behavior in a paracrine manner. Here, in the current review article, the therapeutic properties of Exos and their potential in the alleviation of compromised BBB structure were discussed.Keywords
This publication has 192 references indexed in Scilit:
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trialJournal of Neuroinflammation, 2014
- Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor developmentProceedings of the National Academy of Sciences, 2013
- Pathologies of axonal transport in neurodegenerative diseasesTranslational Neuroscience, 2012
- Juxtacrine and Paracrine Interactions of Rat Marrow-Derived Mesenchymal Stem Cells, Muscle-Derived Satellite Cells, and Neonatal Cardiomyocytes with Endothelial Cells in Angiogenesis DynamicsStem Cells and Development, 2012
- Leukemia cell to endothelial cell communication via exosomal miRNAsOncogene, 2012
- (−)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cellsJournal of Neuroinflammation, 2012
- Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in gliomaOncogene, 2012
- Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Journal of Neuroinflammation, 2012
- Increased p75 neurotrophin receptor expression in the canine distemper virus model of multiple sclerosis identifies aldynoglial schwann cells that emerge in response to axonal damageGlia, 2011
- VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: Involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinasesThrombosis Research, 2007